Hepion Pharmaceuticals, Inc. (HEPA) Social Stream
HEPION PHARMACEUTICALS INC (HEPA) Price Targets From Analysts
Use the tables below to see what analysts covering HEPION PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-26 | 1 | $6 | $6 | $6 | $3.01 | 99.34% |
| 2022-05-18 | 2 | $6 | $3.5 | $4.75 | $3.01 | 57.81% |
| 2022-09-01 | 2 | $6 | $2.5 | $4.25 | $3.01 | 41.2% |
| 2022-11-15 | 1 | $2.5 | $2.5 | $2.5 | $3.01 | -16.94% |
| 2023-01-23 | 1 | $80 | $80 | $80 | $3.01 | 2557.81% |
| 2023-01-31 | 1 | $4 | $2.5 | $3.5 | $3.01 | 16.28% |
| 2023-04-11 | 2 | $80 | $50 | $70 | $3.01 | 2225.58% |
| 2023-05-15 | 2 | $80 | $28 | $60.666 | $3.01 | 1915.48% |
| 2023-10-03 | 1 | $80 | $74 | $77 | $3.01 | 2458.14% |
| 2023-11-13 | 1 | $80 | $22 | $51 | $3.01 | 1594.35% |
Price Target Last Issued November 13, 2023
The Trend in the Analyst Price Target
HEPA's average price target has moved up $45 over the prior 22 months.
HEPA reports an average of 2,711.11% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-23 | 1 | 4 | 2.5 | 3.250 | 0.747 | 335.07% |
| 2023-05-15 | 2 | 80 | 28.0 | 60.666 | 6.700 | 805.46% |
| 2023-10-03 | 1 | 80 | 19.0 | 57.666 | 4.630 | 1145.49% |
| 2023-10-03 | 2 | 80 | 74.0 | 77.000 | 4.630 | 1563.07% |
| 2023-11-13 | 1 | 80 | 22.0 | 51.000 | 3.449 | 1378.69% |
HEPA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 52 weeks, HEPA's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HEPA as an investment opportunity.
- HEPA has a greater number of analysts covering the stock than 19.81% of all US stocks.
- In terms of how HEPION PHARMACEUTICALS INC fares relative to stocks in the micro market cap category, note that its average analyst price target is higher than 718.04% of that group.
- HEPION PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 719.2% of stocks in the micro market cap category.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, HEPION PHARMACEUTICALS INC's variance in analysts' estimates is lower than -673.66% of them.
Stocks similar to HEPION PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LTRN, REVB, and VIRI.
View All Top Stocks by Price Target
What is the outlook for HEPA? Use POWR Ratings for clearer insight into price direction.